CSPC Pharmaceutical Group... (CSPCY)

PNK: CSPCY · Real-Time Price · USD

3.13

0.08 (2.79%)

At close: May 02, 2025, 3:52 PM

CSPC Pharmaceutical Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q3 2018	Q2 2018	Q4 2017	Q2 2017	Q1 2017	Q4 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Jun 30, 2016	Mar 31, 2016
Cash & Equivalents	8.37B	11.98B	10.47B	10.15B	9.07B	11.36B	9.72B	8.65B	6.59B	4.82B	4.6B	4.33B	n/a	3.72B	4.38B	2.71B	n/a	2.9B	1.86B	n/a
Short-Term Investments	2.44B	1.07B	1.63B	3.52B	4.35B	1.77B	3.59B	1.82B	1.68B	2.06B	1.55B	2.29B	n/a	2.63B	1.1B	527.78K	n/a	466.5K	10.45M	n/a
Long-Term Investments	6.44B	4.64B	3.03B	3.73B	3.36B	4.42B	4.24B	4.66B	3.14B	1.83B	1.27B	-1.39B	n/a	-2.02B	-743.52M	270.75M	n/a	153.38M	15.26M	n/a
Other Long-Term Assets	873M	222.58M	2.25B	553.73M	551.87M	513.63M	237.43M	421.34M	-164.32M	172.73M	125.16M	2.62B	n/a	2.63B	1.1B	527.78K	n/a	466.51K	75.78M	n/a
Receivables	11.44B	9.68B	9.48B	6.69B	5.99B	7.98B	6.93B	5.38B	6.22B	4.92B	5.12B	13.14M	n/a	1.00	2.24B	n/a	n/a	2.77B	3.51B	n/a
Inventory	3.46B	3.13B	2.75B	2.52B	2.63B	3.03B	2.2B	2.21B	2.42B	2.84B	2.81B	3.04B	n/a	2.73B	2.42B	2.2B	n/a	1.73B	1.67B	n/a
Other Current Assets	742.58M	9.52B	9.54B	6B	5.32B	6.55B	5.8B	415.06M	5.91B	4.64B	5.18B	4.11B	n/a	4.65B	3.48B	3.55B	n/a	337.53M	302.72M	n/a
Total Current Assets	26.45B	26.67B	24.38B	23.62B	22.84B	24.88B	22.98B	18.88B	18.07B	15.32B	14.83B	13.78B	4.96B	13.72B	11.39B	8.47B	3.24B	7.55B	6.92B	2.3B
Property-Plant & Equipment	11.63B	12.23B	11.36B	10.82B	10.08B	11.7B	11.02B	10.59B	9.99B	10.38B	9.75B	7.2B	n/a	6.64B	6.05B	5.54B	n/a	5.32B	4.89B	n/a
Goodwill & Intangibles	2.47B	2.2B	2.5B	2.34B	1.91B	939.25M	912.58M	958.84M	886.03M	1.69B	1.65B	945.86M	n/a	855.71M	187.94M	224.19M	n/a	171.04M	179.66M	n/a
Total Long-Term Assets	21.42B	19.48B	19.29B	17.56B	16.02B	17.62B	16.51B	16.78B	13.89B	14.12B	12.84B	9.39B	n/a	8.13B	6.61B	6.05B	n/a	5.67B	5.19B	n/a
Total Assets	47.87B	46.15B	43.67B	41.18B	38.85B	42.5B	39.48B	35.65B	31.96B	29.44B	27.66B	22.69B	n/a	21.85B	18B	14.52B	n/a	13.22B	12.04B	n/a
Account Payables	3.23B	2.57B	2.36B	1.77B	1.53B	1.62B	1.48B	1.24B	1.57B	1.43B	2.28B	3.27B	n/a	6.35B	1.3B	1.55B	n/a	1.09B	1.13B	n/a
Deferred Revenue	-251.91M	325.24M	251.91M	788.16M	255.17M	524.05M	395.42M	741.85M	216.47M	563.5M	338.11M	2.00	n/a	1.00	1.69B	1.00	n/a	1.00	2.00	n/a
Short-Term Debt	202.46M	407.7M	55.37M	291.38M	328.21M	n/a	n/a	99M	99M	23M	60M	70.59M	n/a	743.14M	927.28M	833.94M	n/a	897.78M	939.19M	n/a
Other Current Liabilities	6.87B	1.38B	233.51M	1.63B	1.46B	2.26B	1.73B	1.92B	953.29M	1.45B	1.57B	4.91B	n/a	1.53B	2.59B	1.97B	n/a	2.1B	2.32B	n/a
Total Current Liabilities	10.43B	10.15B	9.03B	8.83B	8.46B	8.84B	8.32B	7.47B	8.66B	6.98B	6.98B	7.23B	n/a	7.28B	4.81B	4.35B	n/a	3.66B	3.76B	n/a
Long-Term Debt	n/a	n/a	19.9M	25.42M	10.06M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	50.09M	50M	217.89M	n/a	215.24M	406.11M	n/a
Other Long-Term Liabilities	916.97M	121.35M	372.32M	96.89M	348.72M	97.59M	330.79M	76.73M	38.43M	62.39M	67.93M	201.9M	n/a	513.27M	153.71M	155.16M	n/a	156.66M	151.84M	n/a
Total Long-Term Liabilities	988.23M	738.86M	1.14B	886.28M	964.48M	534.69M	750.51M	490.05M	440.33M	457.11M	534.09M	439.35M	n/a	475.81M	313.68M	479.15M	n/a	433.56M	628.18M	n/a
Total Liabilities	11.42B	10.89B	10.16B	9.72B	9.43B	9.37B	9.07B	7.96B	9.1B	7.43B	7.52B	7.67B	n/a	7.75B	5.13B	4.83B	n/a	4.09B	4.38B	n/a
Total Debt	388.69M	704.81M	415.26M	574.32M	682.81M	115.04M	185.7M	375.51M	317.01M	209.78M	297.88M	70.45M	n/a	793.23M	824.82M	942.99M	n/a	1.02B	1.35B	n/a
Common Stock	11B	10.87B	10.9B	10.75B	10.9B	13.33B	13.1B	12.92B	11.94B	12.19B	12.4B	11.35B	n/a	10.91B	10.8B	9.2B	n/a	9.46B	8.41B	n/a
Retained Earnings	27.26B	21.77B	22.86B	20.84B	19.2B	21.13B	18.87B	15.79B	11.9B	10.86B	8.57B	n/a	n/a	n/a	n/a	5.62B	n/a	5.27B	4.23B	n/a
Comprehensive Income	-3.3B	-1.41B	-1.73B	-1.73B	-1.96B	-2.57B	-2.4B	-2.12B	-1.86B	-2.28B	-2.11B	-2.8B	n/a	n/a	-2.3B	n/a	n/a	-1.88B	n/a	n/a
Shareholders Equity	34.83B	33.1B	31.82B	29.77B	28.05B	31.79B	29.45B	26.48B	21.88B	20.65B	18.74B	15.02B	n/a	13.61B	12.8B	9.61B	n/a	9.05B	7.66B	n/a
Total Investments	8.88B	5.72B	4.66B	7.25B	7.7B	6.18B	7.82B	6.48B	4.83B	3.89B	2.81B	896.76M	n/a	614.49M	356.57M	271.28M	n/a	153.85M	25.71M	n/a